Torsdag 25 Juni | 16:26:34 Europe / Stockholm
Est. tid*
2026-08-25 08:00 Kvartalsrapport 2026-Q2
2026-04-17 - X-dag ordinarie utdelning CANATU 0.00 EUR
2026-04-16 - Årsstämma
2026-03-03 - Bokslutskommuniké 2025
2025-08-29 - Kvartalsrapport 2025-Q2
2025-05-16 - X-dag ordinarie utdelning CANATU 0.00 EUR
2025-05-15 - Årsstämma
2025-03-28 - Bokslutskommuniké 2024
2024-08-29 - Kvartalsrapport 2024-Q2
2024-06-20 - X-dag ordinarie utdelning CANATU 0.00 EUR
2024-06-19 - Årsstämma
2024-02-08 - Bokslutskommuniké 2023
2023-08-24 - Kvartalsrapport 2023-Q2
2023-06-26 - Årsstämma
2023-05-09 - X-dag ordinarie utdelning CANATU 0.00 EUR
2023-03-02 - Bokslutskommuniké 2022
2022-09-15 - Kvartalsrapport 2022-Q2
2022-05-18 - Årsstämma
2022-05-17 - X-dag ordinarie utdelning CANATU 0.00 EUR
LandFinland
ListaFirst North Finland
SektorIndustri
IndustriIndustriprodukter
Canatu är ett teknikbolag verksamt inom djupteknologi som skapar kolnanorör (Canatu CNT), relaterade produkter och tillverkningsutrustning för halvledar-, fordons- och medicinsk diagnostikindustri. Bolaget verkar genom två affärsmodeller, för det första genom egna reaktorer för att utveckla och tillverka CNT-produkter. För det andra säljer bolaget sina CNT-reaktorer och licensierar dess relaterade teknologi, för att kunder ska kunna producera produkterna själva under en begränsad licens.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Canatu changes its leadership structure to drive efficiency and growth

2026-06-25 14:30:00

Canatu Plc
Press Release
25 June 2026 at 3:30 p.m. EEST

Canatu changes its leadership structure to drive efficiency and growth

Canatu Plc, a deep technology company creating advanced carbon nanotubes (CNT), has decided to change its leadership team structure to enable more streamlined operations and further strengthen execution across the organization. At the same time, the company has renamed its Automotive business unit to Robotics, Mobility and Defence to better reflect its current offering and scope of activities. The changes are effective immediately.

The revised leadership team will consist of the Chief Executive Officer (CEO), Maximilian Slawinski, executive management members, the business unit leaders and operational leadership members, who will all report to the CEO.

The executive management will consist of:

  • Chief Financial Officer (CFO)
  • Chief Operating Officer (COO)
  • Chief Technology Officer (CTO)
  • Chief Marketing Officer (CMO)

The business unit leaders are:

  • Senior Vice President, Semiconductor
  • Senior Vice President, Robotics, Mobility and Defence
  • Senior Vice President, Medical Diagnostics

The operational leadership will include:

  • Vice President Legal, General Counsel
  • Vice President Human Resources

All of the above roles together form Canatu’s leadership team.

"This leadership change brings clearer accountability and decision rights across the company while emphasizing business-driven alignment between our business units and corporate functions," says Maximilian Slawinski, CEO of Canatu. "As Canatu continues to evolve, it is important that our organizational structure supports efficient execution, and empowered ownership throughout the organization."

These changes will not affect Canatu’s financial reporting.

Additional information

Maximilian Slawinski, CEO, maximilian.slawinski@canatu.com

Mikko Vesterinen, CFO, mikko.vesterinen@canatu.com

Certified adviser

DNB Carnegie Investment Bank AB (publ), tel. +46 (0) 8 588 685 70

About Canatu

Canatu (CANATU, Nasdaq First North, Finland) is a deep technology scaleup company creating advanced carbon nanotubes (Canatu CNTs), related products, and manufacturing equipment for the semiconductor, robotics, mobility and defence, and medical diagnostics industries. Canatu partners with forerunner companies, together transforming products for better tomorrows with nano carbon.

Canatu’s versatile platform technology has broad potential applications. Its current core includes CNT membranes for extreme ultraviolet (EUV) processes in the semiconductor industry, enabling more effective manufacturing of the most advanced chips. Additionally, electrochemical sensors for medical diagnostics are in the development phase. Canatu’s patented CNT reactors and dry deposition method yield clean and pristine CNTs. The company operates through two business models: selling CNT products directly, as well as selling CNT reactors and licensing the related technology so that customers can produce CNT products under a limited license.

Headquartered in Finland, Canatu also operates in the US, Japan and Taiwan. Founded in 2004 as a spin-off from Aalto University’s Nanomaterials Group, Canatu currently has 185 full-time equivalent employees representing over 35 nationalities, with nearly 20% holding or pursuing doctorates. Discover more at www.canatu.com and follow us on LinkedIn